uptravi Selexipag 1000mcg Tablets
Condition : New
0
From UAE
To Germany
in 5-10 days
Description
How It Works
Uptravi (Selexipag) is a medication used to treat pulmonary arterial hypertension (PAH). It works by targeting the prostacyclin pathway, which plays a critical role in vascular tone and platelet aggregation. Selexipag is a selective prostacyclin receptor agonist that helps to dilate blood vessels in the lungs, reduce vascular resistance, and improve blood flow. By doing so, it helps to alleviate symptoms, improve exercise capacity, and slow disease progression in patients with PAH.List of Side Effects
- Headache
- Diarrhea
- Jaw pain
- Nausea
- Muscle pain
- Flushing
List of Indications
- Pulmonary arterial hypertension (PAH) to delay disease progression and reduce the risk of hospitalization
List of Contraindications
- Hypersensitivity to selexipag or any of the excipients
- Severe hepatic impairment
- Concurrent use with strong CYP2C8 inhibitors (e.g., gemfibrozil)
- Pregnancy and breastfeeding
Price in Different Countries
Country | Price (USD) | Reference Website |
---|---|---|
United States | $8,000 | Drugs.com |
United Kingdom | ?6,500 | NHS UK |
Canada | $9,000 CAD | CanadaDrugs.com |
Australia | $10,000 AUD | Chemist Warehouse |
India | ?600,000 INR | Medlife |
Top 5 Global Brands
- Uptravi (Selexipag) – Actelion Pharmaceuticals
- Orenitram (Treprostinil) – United Therapeutics
- Remodulin (Treprostinil) – United Therapeutics
- Adcirca (Tadalafil) – Eli Lilly
- Revatio (Sildenafil) – Pfizer
Related products
-
Uncategorized
Uralyt-U Exporter in Dubai, UAE | Best Price | Express Shipping | Long Expiry
Rated 0 out of 5Get Price